Beam Appoints Eric Foster as Chief Commercial Officer
Beam Therapeutics appointed Eric Foster as chief commercial officer to lead commercial organization and strategy across its hematology and genetic-disease franchises. Beam explicitly linked the role to preparations for a potential 2027 launch of…
